Health Care

What Analyst Recommend Regarding Healthcare Stock: Gilead Sciences, Inc. (NASDAQ:GILD)

0 14

Gilead Sciences, Inc. (NASDAQ:GILD) closed its last session at $77.62 with the change of -0.56%. The market capitalization of the company is $102.43B with an average Volume of 10.47 million shares. The stock currently has its 52-Week High range of $113.31 and 52-week low range of $76.67. The Price to Book (P/B) ratio stands at 6.69. The stock traded total quantity of 8.32 million shares.

Currently Gilead Sciences, Inc. (GILD) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “17″ Analysts”. “0” rated “Sell” for the company. “10” said the company as a “Hold”. Overweight rating was given by “1” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $107.00 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $124.00 however minimum price target advised by analysts is $80.00. The Median price target for the stock is measured at $109.00.

Presently, Analysts decided consensus EPS estimate of $2.88 for present quarter and one month ago projected EPS estimate was at $2.88. If we take a look at back 3 month ago, consensus EPS estimate was $3.00.

A current consensus EPS estimate for next quarter is at $2.81 and 3 month ago EPS forecast was $3.00. Have a look at back 1 month ago, consensus EPS forecast was seen at $2.82.

For current fiscal year, most recent EPS estimate is set at $11.76 based on Analyst consensus and three month ago consensus EPS opinions was at $12.08. During period one month ago, consensus EPS forecast was decided at $11.78.

A current consensus EPS projection for next fiscal year is observed at $11.65 and one month ago consensus EPS forecast was at $11.69. Take a look at back three month ago, consensus EPS estimate opinions was decided at $12.29 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 14 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 1. 11 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 15 said a “Buy Rating” and 1 announced “Overweight Rating”. 9 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter